Note Agreements in the Health Care Equipment & Supplies Industry
1,513 Contracts & Agreements
- Abbott Laboratories (17 contracts)
- ABIOMED Inc (2)
- Accelerate Diagnostics, Inc (6)
- ACCURAY INC (1)
- AdvanSource Biomaterials Corp (2)
- AETHLON MEDICAL INC (14)
- AIT Therapeutics, Inc. (1)
- ALLIED HEALTHCARE PRODUCTS INC (2)
- Alphatec Holdings, Inc. (6)
- AMERICAN BIO MEDICA CORP (3)
- Angiodynamics Inc (2)
- Apollo Endosurgery, Inc. (2)
- APPYEA, INC (4)
- Apyx Medical Corp (2)
- AquaMed Technologies, Inc. (5)
- ARATANA THERAPEUTICS, INC. (1)
- Arch Therapeutics, Inc. (44)
- ARGOS THERAPEUTICS INC (4)
- Arno Therapeutics, Inc (1)
- ATRION CORP (1)
- AV Therapeutics, Inc. (2)
- Avinger Inc (1)
- AxoGen, Inc. (4)
- Axonics Modulation Technologies, Inc. (2)
- Baxter International Inc. (14)
- Becton Dickinson (53)
- BIOCANCELL THERAPEUTICS INC. (1)
- BIOLASE, INC (1)
- BIOLIFE SOLUTIONS INC (12)
- BIOMIMETIC THERAPEUTICS, INC. (1)
- Bionik Laboratories Corp. (52)
- BioSig Technologies, Inc. (4)
- Boston Scientific (23)
- BRAIN SCIENTIFIC INC. (34)
- Cadrenal Therapeutics, Inc. (5)
- Cascadian Therapeutics, Inc. (1)
- CERUS CORP (1)
- CESCA THERAPEUTICS INC. (15)
- CHEMBIO DIAGNOSTICS, INC. (3)
- Chromocell Therapeutics Corp (35)
- CLARUS THERAPEUTICS INC (1)
- Co-Diagnostics, Inc. (6)
- Conformis Inc (1)
- CONMED Corporation (19)
- CORNERSTONE THERAPEUTICS INC (1)
- Coya Therapeutics, Inc. (1)
- Cryoport, Inc. (7)
- Cutera, Inc. (1)
- CV THERAPEUTICS INC (4)
- Cytosorbents Corp (3)
- D8 Holdings Corp. (5)
- Danaher Corp. (3)
- DarioHealth Corp. (1)
- DELCATH SYSTEMS, INC. (9)
- Dentsply Sirona (1)
- DYNATRONICS CORP (1)
- Eargo, Inc. (1)
- Echo Therapeutics, Inc. (18)
- EKSO BIONICS HOLDINGS, INC. (1)
- electroCore, Inc. (1)
- Electromed, Inc. (2)
- Electromedical Technologies, Inc (44)
- EMBER THERAPEUTICS, INC. - NY (2)
- EMULATE THERAPEUTICS, INC. (9)
- ENCISION INC (4)
- ENDOLOGIX INC (14)
- ENDRA Life Sciences Inc. (5)
- ERBA Diagnostics, Inc. (13)
- FEMASYS INC (1)
- GI DYNAMICS, INC. (31)
- Glolex, Inc. (20)
- GUIDED THERAPEUTICS INC (30)
- Hancock Jaffe Laboratories, Inc. (18)
- HealthCor Catalio Acquisition Corp. (1)
- Heart Test Laboratories, Inc. (7)
- HELIUS MEDICAL TECHNOLOGIES, INC. (2)
- Hill-Rom Holdings Inc. (2)
- Holly Brothers Pictures, Inc. (7)
- Hologic (9)
- HYPERION THERAPEUTICS INC (3)
- HYPERTENSION DIAGNOSTICS INC (2)
- ICU Medical (1)
- IDEXX Laboratories (5)
- IMARX THERAPEUTICS INC (1)
- Innovative Eyewear Inc (2)
- INTRICON CORP (10)
- Invacare Corporation (4)
- Invea Therapeutics, Inc (5)
- INVIVO THERAPEUTICS HOLDINGS CORP. (4)
- INVO Bioscience, Inc. (18)
- iRhythm Technologies, Inc. (2)
- IRIDEX CORP (1)
- LeMaitre Vascular, Inc. (3)
- Longview Acquisition Corp. (2)
- Lucid Diagnostics Inc. (2)
- MAGNA LAB INC (58)
- Masimo (1)
- Medifirst Solutions, Inc. (12)
- Medite Cancer Diagnostics, Inc. (7)
- Medtronic plc (2)
- MELINTA THERAPEUTICS, INC. (3)
- Meridian Bioscience, Inc. (4)
- MICRO THERAPEUTICS INC (2)
- Microbot Medical Inc. (3)
- MICRON SOLUTIONS INC (5)
- MILESTONE SCIENTIFIC INC. (1)
- MISONIX INC (1)
- Modular Medical, Inc. (4)
- Motus GI Holdings, Inc. (1)
- MRI INTERVENTIONS, INC. (5)
- MYOMO INC (9)
- NanoVibronix, Inc. (27)
- Nemaura Medical Inc. (9)
- Neogen Corporation (1)
- Neuronetics, Inc. (3)
- NEUROONE MEDICAL TECHNOLOGIES Corp (19)
- NEXEON MEDSYSTEMS INC (3)
- NON INVASIVE MONITORING SYSTEMS INC (82)
- OBALON THERAPEUTICS INC (1)
- Ocata Therapeutics, Inc. (3)
- ORCHESTRA THERAPEUTICS, INC. (5)
- Orexigen Therapeutics, Inc. (2)
- ORTHOPEDIATRICS CORP (9)
- OSIRIS THERAPEUTICS, INC. (9)
- OxySure Therapeutics, Inc. (9)
- OZOP SURGICAL CORP. (27)
- PAVmed Inc. (8)
- PERNIX THERAPEUTICS HOLDINGS, INC. (3)
- PetVivo Holdings, Inc. (14)
- PRECISION OPTICS CORPORATION, INC. (85)
- Precision Therapeutics Inc. (35)
- Presbia PLC (1)
- Primus Therapeutics Inc. (1)
- PRO DEX INC (8)
- Pulse Biosciences, Inc. (1)
- Q Therapeutics, Inc. (2)
- QUANTRX BIOMEDICAL CORP (7)
- Quotient Ltd (1)
- Ra Medical Systems, Inc. (1)
- REMEDENT, INC. (1)
- RemSleep Holdings Inc. (12)
- ReShape Lifesciences Inc. (1)
- ResMed (3)
- Restoration Robotics, Inc. (20)
- RETRACTABLE TECHNOLOGIES INC (1)
- ReWalk Robotics Ltd. (1)
- RTI Surgical Holdings, Inc. (4)
- RxSight, Inc. (1)
- Salona Global Medical Device Corp (3)
- Sandbridge Acquisition Corp (1)
- SANUWAVE Health, Inc. (35)
- SECOND SIGHT MEDICAL PRODUCTS INC (2)
- Senseonics Holdings, Inc. (6)
- Sensus Healthcare, Inc. (1)
- Sharps Technology Inc. (2)
- Sientra, Inc. (3)
- Sintx Technologies, Inc. (12)
- STAAR SURGICAL CO (5)
- STEMLINE THERAPEUTICS INC (1)
- Stereotaxis, Inc. (5)
- STERIS Ltd (10)
- STERIS plc (9)
- STRATA Skin Sciences, Inc. (5)
- Stryker Corp. (5)
- Synvista Therapeutics, Inc. (1)
- Talon Therapeutics, Inc. (1)
- Targanta Therapeutics Corp. (3)
- TearLab Corp (3)
- TechCare Corp. (10)
- Teleflex Inc (3)
- Tenon Medical, Inc. (17)
- THC Therapeutics, Inc. (4)
- The Cooper Companies (2)
- Tivic Health Systems, Inc. (7)
- Tobira Therapeutics, Inc. (2)
- TRANSENTERIX INC. (6)
- TransMedics Group, Inc. (1)
- UTAH MEDICAL PRODUCTS INC (1)
- Valeritas Holdings Inc. (5)
- VASO Corp (1)
- VERMILLION, INC. (4)
- VIVEVE MEDICAL, INC. (3)
- VIVOS INC (3)
- WOUND MANAGEMENT TECHNOLOGIES, INC. (13)
- Xtant Medical Holdings, Inc. (4)
- Zander Therapeutics, Inc (2)
- Zimmer Biomet Holdings (4)
- Zosano Pharma Corp (11)
- ZYNEX INC (4)
- Form of Note (BioSig Technologies, Inc., Filed With SEC on March 12, 2024)
- Form of 3.500% Senior Note due 2032 (Boston Scientific, Filed With SEC on February 27, 2024)
- Form of 3.375% Senior Note due 2029 (Boston Scientific, Filed With SEC on February 27, 2024)
- Promissory Note, dated February 9, 2024, issued by Citrine Global, Corp. to 1800 Diagonal Lending LLC (TechCare Corp., Filed With SEC on February 15, 2024)
- First Amendment to Senior Secured Convertible Note (September Bridge Financing) (Chromocell Therapeutics Corp, Filed With SEC on February 12, 2024)
- Fourth Amendment to Senior Secured Convertible Note (April Bridge Financing) (Chromocell Therapeutics Corp, Filed With SEC on February 12, 2024)
- First Amendment to Promissory Note dated November 13, 2023 between the Company and the Lender (PetVivo Holdings, Inc., Filed With SEC on February 9, 2024)
- Promissory Note dated October 16, 2023 between the Company and the Lender (PetVivo Holdings, Inc., Filed With SEC on February 9, 2024)
- Form of 5.110% Notes due February 8, 2034 of Becton, Dickinson and Company (Becton Dickinson, Filed With SEC on February 8, 2024)
- Form of 4.874% Notes due February 8, 2029 of Becton, Dickinson and Company (Becton Dickinson, Filed With SEC on February 8, 2024)
- Form of 3.519% Notes due February 8, 2031 of Becton, Dickinson and Company (Becton Dickinson, Filed With SEC on February 8, 2024)
- Sixth Amended and Restated Investor Promissory Note Issued by the Company (Chromocell Therapeutics Corp, Filed With SEC on January 30, 2024)
- Side Letter to Fifth Amended and Restated Investor Promissory Note Issued by the Company (Chromocell Therapeutics Corp, Filed With SEC on January 30, 2024)
- Form of Future Advance Convertible Promissory Note issued to certain purchasers, dated January 21, 2024 (SANUWAVE Health, Inc., Filed With SEC on January 25, 2024)
- VENUS CONCEPT INC. SECURED SUBORDINATED CONVERTIBLE NOTE (Restoration Robotics, Inc., Filed With SEC on January 19, 2024)
- VENUS CONCEPT INC. SECURED SUBORDINATED CONVERTIBLE NOTE (Restoration Robotics, Inc., Filed With SEC on January 19, 2024)
- NOTE PURCHASE AND REGISTRATION RIGHTS AGREEMENT (Restoration Robotics, Inc., Filed With SEC on January 19, 2024)
- Amendment No. 1 to Director Promissory Note Issued by the Company (Chromocell Therapeutics Corp, Filed With SEC on January 16, 2024)
- Second Amended and Restated October Promissory Note Issued by the Company (MDB Merchants Park LLC) (Chromocell Therapeutics Corp, Filed With SEC on January 16, 2024)
- Second Amended and Restated October Promissory Note Issued by the Company (Camden Capital LLC) (Chromocell Therapeutics Corp, Filed With SEC on January 16, 2024)
- Second Amended and Restated October Promissory Note Issued by the Company (Balmoral Financial Group LLC) (Chromocell Therapeutics Corp, Filed With SEC on January 16, 2024)
- Second Amended and Restated October Promissory Note Issued by the Company (AME Equities LLC) (Chromocell Therapeutics Corp, Filed With SEC on January 16, 2024)
- Fifth Amended and Restated Investor Promissory Note Issued by the Company (Chromocell Therapeutics Corp, Filed With SEC on January 16, 2024)
- Side Letter to Fourth Amended and Restated Investor Promissory Note Issued by the Company (Chromocell Therapeutics Corp, Filed With SEC on January 16, 2024)
- Third Amendment to Senior Secured Convertible Note (April Bridge Financing) (Chromocell Therapeutics Corp, Filed With SEC on January 16, 2024)
- Amendment to Grid Note, by and between Registrant and InveniAI LLC, dated January 8, 2024 (Invea Therapeutics, Inc, Filed With SEC on January 12, 2024)
- Form of Amendment No. 9 to the Third Notes, dated January 5, 2024 (Arch Therapeutics, Inc., Filed With SEC on January 11, 2024)
- Form of Amendment No. 14 to the Second Notes, dated January 5, 2024 (Arch Therapeutics, Inc., Filed With SEC on January 11, 2024)
- Form of Amendment No. 14 to the First Notes, dated January 5, 2024 (Arch Therapeutics, Inc., Filed With SEC on January 11, 2024)
- Amendment No. 3 to Second Amended and Restated Convertible Promissory Note, date January 5, 2024, between ThermoGenesis Holdings, Inc. and Boyalife Group, Inc (CESCA THERAPEUTICS INC., Filed With SEC on January 10, 2024)
- Form of Future Advance Convertible Promissory Note issued to certain purchasers, dated December 30, 2023 (SANUWAVE Health, Inc., Filed With SEC on January 3, 2024)
- Amended and Restated Revolving Note dated as of December 21, 2023 by Atrion Corporation, as Borrower, in favor of Wells Fargo Bank, National Association, as Lender (ATRION CORP, Filed With SEC on December 28, 2023)
- First Amendment to Note Purchase Agreement, dated December 11, 2023, between the Company and certain investors named therein (Accelerate Diagnostics, Inc, Filed With SEC on December 13, 2023)
- Form of Note (Tenon Medical, Inc., Filed With SEC on November 28, 2023)
- Form of Amendment No. 8 to the Third Notes, dated November 21, 2023 (Arch Therapeutics, Inc., Filed With SEC on November 22, 2023)
- Form of Amendment No. 13 to the Second Notes, dated November 21, 2023 (Arch Therapeutics, Inc., Filed With SEC on November 22, 2023)
- Form of Amendment No. 13 to the First Notes, dated November 21, 2023 (Arch Therapeutics, Inc., Filed With SEC on November 22, 2023)
- Secured Promissory Note issued by the registrant, Dermal Diagnostics Limited and Trial Clinic Limited in favor of Streeterville Capital, LLC (Nemaura Medical Inc., Filed With SEC on November 21, 2023)
- Note Conversion Letter Agreement, dated November 16, 2023, by and between Heart Test Laboratories, Inc. and John Q. Adams (Heart Test Laboratories, Inc., Filed With SEC on November 17, 2023)
- Note Conversion Letter Agreement, dated November 16, 2023, by and between Heart Test Laboratories, Inc. and Matthews Southwest Holdings, Inc (Heart Test Laboratories, Inc., Filed With SEC on November 17, 2023)